BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25142943)

  • 21. The Hyperdense middle cerebral artery sign is associated with poor leptomeningeal collaterals in acute ischemic stroke: a retrospective study.
    Hong Y; Fang J; Ma M; Su W; Zhou M; Tang L; Tang H; He L
    BMC Neurol; 2022 Feb; 22(1):51. PubMed ID: 35148711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic capacity of hyperdense middle cerebral artery sign in anterior circulation acute ischaemic stroke patients receiving reperfusion therapy: a systematic review and meta-analysis.
    Shi C; Killingsworth MC; Bhaskar SMM
    Acta Neurol Belg; 2022 Apr; 122(2):423-435. PubMed ID: 34095978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperdense middle cerebral artery sign in large cerebral infarction.
    Hou J; Sun Y; Duan Y; Zhang L; Xing D; Lee X; Yang B
    Brain Behav; 2021 May; 11(5):e02116. PubMed ID: 33764692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hyperdense anterior cerebral artery sign (HACAS) as a computed tomography marker for acute ischemia in the anterior cerebral artery territory.
    Jensen UR; Weiss M; Zimmermann P; Jansen O; Riedel C
    Cerebrovasc Dis; 2010; 29(1):62-7. PubMed ID: 19907164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. M1 susceptibility vessel sign and hyperdense middle cerebral artery sign in hyperacute stroke patients.
    Sakamoto Y; Kimura K; Sakai K
    Eur Neurol; 2012; 68(2):93-7. PubMed ID: 22759539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proximal hyperdense middle cerebral artery sign is associated with increased risk of asymptomatic hemorrhagic transformation after endovascular thrombectomy: a multicenter retrospective study.
    Kang Z; Wu L; Sun D; Zhou G; Wu X; Qiu H; Mei B; Zhang J
    J Neurol; 2023 Mar; 270(3):1587-1599. PubMed ID: 36446912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis.
    Forlivesi S; Bovi P; Tomelleri G; Micheletti N; Carletti M; Moretto G; Cappellari M
    J Thromb Thrombolysis; 2017 Jan; 43(1):86-90. PubMed ID: 27469539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of length of hyperdense MCA sign in acute ischemic stroke predicts disappearance after IV tPA.
    Shobha N; Bal S; Boyko M; Kroshus E; Menon BK; Bhatia R; Sohn SI; Kumarpillai G; Kosior J; Hill MD; Demchuk AM
    J Neuroimaging; 2014; 24(1):7-10. PubMed ID: 23316960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance.
    Kharitonova T; Thorén M; Ahmed N; Wardlaw JM; von Kummer R; Thomassen L; Wahlgren N;
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):273-8. PubMed ID: 18931005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CT-Defined Hyperdense Arterial Sign as a Marker for Acute Intracerebral Large Vessel Occlusion.
    Lim J; Magarik JA; Froehler MT
    J Neuroimaging; 2018 Mar; 28(2):212-216. PubMed ID: 29134723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy.
    Tomsick T; Brott T; Barsan W; Broderick J; Haley EC; Spilker J; Khoury J
    AJNR Am J Neuroradiol; 1996 Jan; 17(1):79-85. PubMed ID: 8770253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disappearing hyperdense middle cerebral artery sign is associated with striatocapsular infarcts on follow-up CT in ischemic stroke patients treated with intravenous thrombolysis.
    van Overbeek EC; Knottnerus IL; van Oostenbrugge RJ
    Cerebrovasc Dis; 2010 Aug; 30(3):285-9. PubMed ID: 20664262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperdense middle cerebral artery sign predicts favorable outcome in patients undergoing mechanical thrombectomy.
    Merlino G; Tereshko Y; Pez S; Bagatto D; Gigli GL; Lorenzut S; Sponza M; Vit A; Gavrilovic V; Marotti N; Janes F; Bax F; Valente M
    J Thromb Thrombolysis; 2023 Feb; 55(2):312-321. PubMed ID: 36434302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical diffusion mismatch better discriminates infarct growth than mean transit time-diffusion weighted imaging mismatch in patients with middle cerebral artery-M1 occlusion and limited infarct core.
    Nogueira RG; Kemmling A; Souza LM; Payabvash S; Hirsch JA; Yoo AJ; Lev MH
    J Neurointerv Surg; 2017 Feb; 9(2):127-130. PubMed ID: 26957483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperdense basilar artery sign on unenhanced CT predicts thrombus and outcome in acute posterior circulation stroke.
    Goldmakher GV; Camargo EC; Furie KL; Singhal AB; Roccatagliata L; Halpern EF; Chou MJ; Biagini T; Smith WS; Harris GJ; Dillon WP; Gonzalez RG; Koroshetz WJ; Lev MH
    Stroke; 2009 Jan; 40(1):134-9. PubMed ID: 19038918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large middle cerebral artery infarctions and the hyperdense middle cerebral artery sign in patients with atrial fibrillation.
    Berge E; Nakstad PH; Sandset PM;
    Acta Radiol; 2001 May; 42(3):261-8. PubMed ID: 11350283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of deep learning-assisted identification of hyperdense MCA sign in acute ischemic stroke: comparison with readers' performance.
    Shinohara Y; Takahashi N; Lee Y; Ohmura T; Umetsu A; Kinoshita F; Kuya K; Kato A; Kinoshita T
    Jpn J Radiol; 2020 Sep; 38(9):870-877. PubMed ID: 32399602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disappearance of the hyperdense MCA sign after stroke thrombolysis: implications for prognosis and early patient selection for clot retrieval.
    Elofuke P; Reid JM; Rana A; Macleod MJ
    J R Coll Physicians Edinb; 2016 Jun; 46(2):81-86. PubMed ID: 27929569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of mismatch in acute ischaemic stroke.
    Sztriha LK; Cusack U; Kandasamy N; Jarosz J; Kalra L
    J Neurol Sci; 2013 Nov; 334(1-2):10-3. PubMed ID: 23978421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator.
    Manelfe C; Larrue V; von Kummer R; Bozzao L; Ringleb P; Bastianello S; Iweins F; Lesaffre E
    Stroke; 1999 Apr; 30(4):769-72. PubMed ID: 10187877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.